A phase I study of oral panobinostat (LBH589) alone and in combination with docetaxel (Doc) and prednisone in castration-resistant prostate cancer (CRPC)
暂无分享,去创建一个
P. Atadja | H. Scher | D. Rathkopf | J. Picus | D. George | R. Ross | K. Culver | B. Wong | E. Tanaka | Yingbo Chen | W. Yang